Science and Research committee  GlycoNet, for example, is a network connecting scientists, entrepreneurs, the investment community, students, everybody. It's an end-to-end network. The objective of having public-private partnerships, both from a funding perspective and from training and enabling perspective, is that many of the jobs are in industry, and some of the jobs are in academia.

Science and Research committee  Yes. I'd be happy to. We have some challenging IP policies. It's a potpourri of policies across universities. One could do a whole Ph.D. study on that. It is challenging. From institution to institution, some are more progressive and some are not. IP should always be inventor-driven.

Science and Research committee  Thank you. Good evening everybody. I'd first like to acknowledge that I'm speaking from the ancestral territories of the Squamish, Tsleil-Waututh and Musqueam peoples here in Vancouver. It's my pleasure to present to you today. I'll pick up from where Elizabeth left off. To ensure a truly sustainable and optimized platform in glycomics through GlycoNet and for the full economic benefit of GlycoNet to be realized, we need sustained public-private support on an ongoing basis.